Igwok Solution for Infusion contains Human Normal Immunoglobulin (5 gm) and is indicated for intravenous administration to provide passive immunity in patients with immunodeficiency disorders or those requiring immunomodulation. This preparation consists of purified immunoglobulin G (IgG) derived from pooled human plasma, ensuring a broad spectrum of antibodies against various pathogens. Igwok is primarily used in the treatment of primary humoral immunodeficiency diseases, including common variable immunodeficiency and X-linked agammaglobulinemia, to reduce the frequency and severity of infections. Additionally, it may be employed in certain autoimmune and inflammatory conditions where immune modulation is beneficial. The solution is supplied in a sterile, ready-to-use form and should be administered under medical supervision with appropriate monitoring for adverse reactions such as hypersensitivity or infusion-related events. Dosage and infusion rates must be individualized based on the patient’s clinical condition, weight, and response to therapy. Igwok Solution for Infusion is contraindicated in patients with known hypersensitivity to human immunoglobulins or excipients. Proper screening of plasma donors and rigorous manufacturing processes minimize the risk of transmission of infectious agents. This product should be stored according to recommended conditions to maintain stability and efficacy.